Martin Shkreli Appears at House Hearing on Drug Pricing, Refuses to Answer Questions

Pharmaceutical chief Martin Shkreli has arrived at a hearing where U.S. lawmakers want to hear from about severe hikes for a drug sold by a company that he acquired.But it’s unlikely the former CEO of Turing Pharmaceuticals will answer questions in his appearance Thursday before the House Oversight and Government Reform Committee.

Continue reading